Indian expert panel reviews Covid-19 vaccines, to meet again friday
Coronavirus chronicle
The Indian Government appointed panel of experts on Wednesday took Bharat Biotech and Pfizer into consideration among the coronavirus vaccines filed for emergency use of approval by the Serum Institute of India.
Serum Institute which is making the vaccine "Covidshield" developed by Oxford University and pharma major AstraZeneca and Bharat Biotech which has partnered the Indian Council of Medical Research (ICMR) for its "Covaxin" made presentations before the panel, reports NDTV.
Pfizer has sought more time to present their data.
The analysis of the data is ongoing and the panel will meet again on Friday, a government statement said.
Once the vaccines are cleared by the expert panel, the applications will move to the Drugs Controller General of India (DCGI) for final approval. The government wants to start administering the shots starting next month.
India, which has the world's second-highest number of Covid-19 infections in the world after the United States, plans to inoculate 30 crore people in the next six to eight months and the affordable Oxford vaccine is its biggest hope.
Comments
While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.